Ameriprise
TCON

Ameriprise’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Ameriprise’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,424
Closed -$728K – 3981
2021
Q1 		$728K Sell
4,424
-493
-10% -$94.9K ﹤0.01% 3264
2020
Q4 		$1.15M Buy
+4,917
New +$684K ﹤0.01% 3022
2018
Q2 		– Sell
-186
Closed -$86K – 3715
2018
Q1 		$86K Buy
186
+123
+195% +$67.1K ﹤0.01% 3563
2017
Q4 		$42K Buy
+63
New +$38K ﹤0.01% 3602

Other funds holding TCON

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ameriprise's TCON Position: Q2 2021 in Review

Ameriprise sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2021, closing a stake of 4,424 shares — an estimated $728K sold.

Ameriprise first reported a position in TCON in Q4 2017 and held it in 4 quarters. The position peaked at $1.15M in Q4 2020. 44 funds tracked by Wall St. Rank hold TCON as of Q2 2021.

  • Ameriprise reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ameriprise sold 4,424 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $728K.
  • Ameriprise first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 4 quarters.
  • Ameriprise's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $1.15M in Q4 2020.
  • 44 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.